| Structure |
Chemical Name |
CAS |
MF |
 |
Empagliflozin Impurity 21 |
|
|
![ethyl (S)-10-fluoro-3-methyl-7-oxo- 2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylate](/CAS/20180703/GIF/431058-46-7.gif) |
ethyl (S)-10-fluoro-3-methyl-7-oxo- 2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylate |
431058-46-7 |
C15H14FNO4 |
 |
WGEFOIHAXGTXJE-RTMVWDMESA-N |
1373171-12-0 |
C48H61NO14 |
 |
Erlotinib Imp.18 |
|
|
 |
2-ethoxy-1-methoxy-4-(2-(methylsulfonyl)ethyl)benzene |
|
C12H18O4S |
 |
Tofacitinib Impurity 6 |
1640972-35-5 |
C16H22N6O |
 |
Roxithromycin Impurity J |
|
|
 |
Sitagliptin IMpurity 1 |
|
|
 |
Fosaprepitant Impurity 13 |
|
|
 |
ビス(P-アセチルアミノフェニル)エーテル |
3070-86-8 |
C16H16N2O3 |
 |
Moxifloxacin degradation impurity 36 |
|
|
 |
RebaMipide 2-Chloro IMpurity |
90098-06-9 |
C19H15ClN2O4 |
 |
Afatinib Impurity 70 |
125781-04-6 |
C4H7ClO2 |
 |
Avibactam Impurity 39 |
2089462-91-7 |
C15H22N2O3 |
 |
Olaparib Impurity 32 |
|
|
 |
lithiuM 2-(4-(Methylsulfonyl)phenyl)acetate |
1421227-96-4 |
C9H11LiO4S |
 |
4-aMino-5-chloro-2,3-dihydro-N-4-piperidinyl-7-BenzofurancarboxaMide |
137211-64-4 |
C14H18ClN3O2 |
 |
Vortioxetine Impurity 3 |
508233-82-7 |
C17H20N2S |
 |
Azilsartan impurity Y |
|
|
 |
Deferasirox IMpurity 2 |
|
|
 |
Palbociclib Impurity 61 |
2222404-53-5 |
C14H20N4O4 |
 |
Topiroxostat Impurity 5 |
1199273-82-9 |
C14H7N7 |
![Benzenesulfonamide, 4-[5-(4-methylphenyl)-2-oxido-3-(trifluoromethyl)-1H-pyrazol-1-yl]-](/CAS/20200401/GIF/2356153-95-0.gif) |
Benzenesulfonamide, 4-[5-(4-methylphenyl)-2-oxido-3-(trifluoromethyl)-1H-pyrazol-1-yl]- |
2356153-95-0 |
C17H14F3N3O3S |
 |
Linagliptin Impurity P |
|
|
 |
Bendamustine Related Impurity 17 |
|
|
 |
Cefdinir Impurity F (CP) |
|
|
 |
Oseltamivir Impurity 10 |
2081110-43-0 |
C16H28N2O4 |
 |
N-(4-methyl-3-(N-(4-(pyridin-3-yl)pyrimidin-2-yl)acetamido)phenyl)-4-((4-methylpiperazin-1-yl)methyl)benzamide |
|
C31H33N7O2 |
 |
Fondaparinux sodium impurity 4 |
|
|
 |
Topiroxostat Impurity 1 |
|
|
 |
Bortezomib Impurity 32 |
1310383-72-2 |
C17H31BF3NO5 |
 |
Afatinib Impurity 50 |
|
|
 |
1,1'-ビフェニル-2-イルカルバミド酸 |
50443-60-2 |
C13H11NO2 |
 |
((R)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxaMido)propanaMido)butyl)boronic acid |
1132709-15-9 |
C19H25BN4O4 |
 |
Anagrelide Impurity 2 HCl |
|
|
 |
Tinidazole Impurity 2 |
140165-55-5 |
C6H12N2O4S |
 |
Edoxaban Impurity 38 |
2081883-53-4 |
C14H27N3O3 |
 |
Febuxostat Impurity 61 |
|
|
 |
Ticagrelor Impurity 71 |
|
|
 |
Amlodipine Impurity 33 |
|
C26H31ClN2O8S |
 |
Brexpiprazole Impurity 4 |
2116542-20-0 |
C25H27N3O2S |
 |
(R)-(R)-1-methylpyrrolidin-3-yl 2-cyclopentyl-2-hydroxy-2-phenylacetate(WXC03446) |
616866-21-8 |
C18H25NO3 |
 |
8-Methoxyquinolin-2(1H)-one |
22614-69-3 |
C10H9NO2 |
 |
Tofacitinib Impurity 117 |
|
|
 |
Tofacitinib Impurity 118 |
|
|
 |
Verapamil Impurity |
1551304-28-9 |
C12H19NO2 |
 |
Milnacipran Impurity 3 |
1353644-50-4 |
C15H20ClNO |
 |
Oxytocin Impurity 3 |
|
|
 |
Demiditraz IMpurity |
944267-48-5 |
C19H18N2O |
 |
Pitavastatin Impurity 46 |
|
|
 |
Ticagrelor Related Compound 71 |
1548397-10-9 |
C7H8ClN3O3S |
 |
Metoprolol IMpurity V |
|
C15H25NO3 |
 |
Varenicline Impurity 1 |
|
|
 |
Flurbiprofen Impurity 7 |
|
|
 |
Nebivolol Impurity 3 |
1029684-20-5 |
C18H20FNO2 |
 |
Empagliflozin Impurity 18 |
|
|
 |
Lincomycin sulfoxide Impurity 2 |
|
|
 |
Ambrisentan Impurity E |
1312092-82-2 |
C21H18N2O3 |
 |
Deschloro Cetirizine Dihydrochloride |
83881-54-3 |
C21H26N2O3 |
 |
Trelagliptin Impurity SJ |
2087874-94-8 |
C40H42F2N10O6 |
 |
blonanserin impurity O |
|
|
 |
Aripiprazole iMpurity 2 |
1424857-93-1 |
C14H18Cl2N2 |
 |
4,4'-(2-HYDROXY-1,3-PROPANDIYLDIOXY)BIS(2-PHENYLACETAMIDE) |
141650-31-9 |
C19H22N2O5 |
![(R)-N-[1-(5,6,7,8-テトラヒドロナフタレン-1-イル)エチル]-3-[3-(トリフルオロメチル)フェニル]-1-プロピルアミン](/CAS/20150408/GIF/1229224-93-4.gif) |
(R)-N-[1-(5,6,7,8-テトラヒドロナフタレン-1-イル)エチル]-3-[3-(トリフルオロメチル)フェニル]-1-プロピルアミン |
1229224-93-4 |
C22H26F3N |
 |
D-Streptamine, o-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1-6)-o-(6-amino-6-deoxy-alpha-D-glucopyranosyl-(1-4))-N(sup 3)-(4-amino-2-hydroxybutyryl)-2-deoxy- |
50725-24-1 |
C22H43N5O13 |
 |
4'-Deoxy Vincristine |
68135-16-0 |
C46H56N4O9 |
 |
Deferasirox Methyl Ester |
1266741-05-2 |
C22H17N3O4 |
 |
Parecoxib sodium Impurity 35 |
|
|
 |
Pitavastatin Impurity 44 |
586966-55-4 |
C29H32FNO4 |
 |
Almotriptan Impurity 1 |
334981-13-4 |
C17H25N3O3S |
 |
Empagliflozin Impurity 24 |
|
|
 |
Avibactam Impurity B |
|
|
 |
5-Bromo-1-(4-fluorophenyl)-1,3-dihydro-N,N-dimethyl-1-isobenzofuranpropanamine ethanedioate (1:1) |
64372-43-6 |
C21H23BrFNO5 |
 |
Ibrutinib Impurity 27 |
2031255-26-0 |
C26H28N6O3 |
![[1,1′-Biphenyl]-2-sulfonamide, 4′-[(2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl]-N-(4,5-dimethyl-3-isoxazolyl)-2′-(hydroxymethyl)-](/CAS/20240320/GIF/254740-63-1.gif) |
[1,1′-Biphenyl]-2-sulfonamide, 4′-[(2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl]-N-(4,5-dimethyl-3-isoxazolyl)-2′-(hydroxymethyl)- |
254740-63-1 |
C30H36N4O5S |
 |
Afatinib Impurity 52 |
|
|
 |
Everolimus Related Compound 3 |
147438-30-0 |
C32H49NO9 |
 |
Empagliflozin Impurity 78 |
|
|
 |
Tofacitinib Impurity 89 |
|
|
![4-[-((-((4-(5-(Bis(2-hydroxyethyl)aMino)-1-Methyl-1H-benzo[d]iMidazol-2-yl)butanoyl)oxy)ethyl)(2-hydroxyethyl)aMino)-1-Methyl-1H-benzo[d]iMidazol-2-yl)butanic Acid](/CAS/GIF/1228551-91-4.gif) |
4-[-((-((4-(5-(Bis(2-hydroxyethyl)aMino)-1-Methyl-1H-benzo[d]iMidazol-2-yl)butanoyl)oxy)ethyl)(2-hydroxyethyl)aMino)-1-Methyl-1H-benzo[d]iMidazol-2-yl)butanic Acid |
1228551-91-4 |
C32H41Cl3N6O4 |
 |
Etoricoxib Impurity 17 |
|
|
 |
2-(Dimethylamino)ethyl 4-methylbenzenesulfonate |
123091-15-6 |
C11H17NO3S |
 |
N-Des-tetrahydrofuran N-(6,7-Dimethoxy-4,4a-dihydroquinazolin-4-amine) Alfuzosin |
928780-95-4 |
C24H30N8O4 |
 |
Canagliflozin Impurity 63 |
|
|
 |
Atracurium Impurity O |
|
|
 |
Sulpiride Impurity 2 |
|
|
 |
Pranoprofen Impurity 5 |
145986-74-9 |
C16H15NO3 |
 |
Linagliptin Impurity 33 |
2443735-53-1 |
C38H42N10O4 |
 |
(E)-3'-(2-(1-(3,4-dimethylphenyl) |
|
|
 |
Ivabradine Impurity 1 Hydrochloride |
85175-52-6 |
C16H25ClN2O3 |
![(1R,3R)-1-(benzo[d][1,3]dioxol-5-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic acid](/CAS/20180601/GIF/474668-76-3.gif) |
(1R,3R)-1-(benzo[d][1,3]dioxol-5-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic acid |
474668-76-3 |
C19H16N2O4 |
 |
Afatinib IMpurity G |
|
|
 |
Tofacitinib Impurity 20 |
1092578-44-3 |
C27H31N5O2S |
 |
Lamivudine Impurity 5 |
|
|
 |
Avatrombopag Impurity 40 |
|
|
 |
Lenvatinib Impurity LFZZ-9 |
|
C43H38Cl2N8O8 |
 |
Aprepitant |
170902-80-4 |
C20H18F7NO2 |
 |
Amifostine Impurity 2 |
|
|
 |
2,2'-(4,10-bis((trans)-1,3,4-trihydroxybutan-2-yl)-1,4,7,10-tetraazacyclododecane-1,7-diyl)diacetic acid 4HCl |
|
|
 |
"mixture of 2-amino-9-[[2-(hydroxymethoxy) ethoxy]methyl]-1,9-dihydro-6H-purin-6-one and 2-amino-9-[[2-(hydroxyethoxy)methoxy]methyl]-1,9- dihydro-6H-purin-6-one," |
|
|